ARTICLE
|
doi:10.20944/preprints202208.0488.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
chemoradiation; preoperative; neoadjuvant; TN/HER-2+ phenotype; pathological response; breast cancer
Online: 29 August 2022 (10:47:34 CEST)